跳至主要内容
临床试验/NCT00594022
NCT00594022已完成不适用

The Effect of Vestibular Stimulation on Transient Insomnia Induced by a Five-hour Phase Advance of Sleep Time

Philips Respironics6 个研究点 分布在 1 个国家目标入组 349 人开始时间: 2007年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
349
试验地点
6
主要终点
Latency to Persistent Sleep (LPS)

研究概览

简要总结

The purpose of this study is to determine whether a small electrical current to the vestibular nerve (balance organ) will decrease the time it take for participants to fall asleep.

详细描述

This 2 arm study will look at the proposed treatment (electrical stimulation of the vestibular nerve) versus a sham or placebo device. The effect of the device will be evaluated in a study that uses normal sleepers and advances them(puts them to bed 5-hours earlier than normal) to see if they fall asleep faster in one group or the other. Stimulation in the treated or sham group is only for the first hour after lights off.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
21 Years 至 50 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Males and females, ages 21- 50 attempts will be made to enroll equal distributions of males and females
  • •Able and willing to provide written informed consent
  • •Self reported habitual bedtime between 2100 and 0100 hours, which does not vary by more than 1 hour at least 5 nights per week
  • •Self reported 7.5-9 hrs. habitual sleep time
  • •Able to commit to 9 hrs of sleep opportunity throughout the study, but especially for the 3 nights prior to their PSG
  • •Pass Berlin questionnaire, i.e. low likelihood of sleep disordered breathing
  • •No history or evidence of RLS(restless leg syndrome) /PLMS (periodic limb movement syndrome) /Narcolepsy, no non-respiratory related sleep disorders.

排除标准

  • •Regular use of a pack or more per day of tobacco products
  • •Typically consumes more than 2 (12 oz) caffeinated beverages per day
  • •Self reported history of motion sickness
  • •Participation in a study of investigational or marketed drugs or devices during the 30-day period prior to the start of the study or during the study
  • •Clinically significant medical or psychiatric condition as determined by the investigator
  • •Probable diagnosis of a current sleep disorder including but not limited to insomnia, sleep apnea, restless legs syndrome, or periodic limb movement disorder
  • •History of current or recent (e.g. within past 5 years) alcohol, narcotic or any other drug abuse as defined by the Diagnostic and Statistical Manual of Mental Disorders of the American Psychiatric Association, 4th Edition (DSM-IV)
  • •Currently works night shift or rotating shift
  • •Travel or planned travel across more than 1 time zone within one week prior to randomization
  • •Use of any medication that, in the opinion of the investigator, may alter sleep or wakefulness. (See Appendix E: Guideline For Medications Commonly Associated With Alterations Of Sleep / Wake Functioning). Subjects will undergo urine drug testing.
  • •Consumption of more than 14 alcoholic drinks per week, or the recent consumption of more than 4 alcoholic drinks in one night. Subjects will be tested for alcohol, using a saliva test kit.
  • •Pregnancy (will confirm absence of pregnancy with a urine or serum pregnancy test in women's of child bearing age).
  • •Presence of a pacemaker
  • •Presence of epilepsy or other uncontrolled medical conditions.
  • •Prior participation in a VirtuSom protocol
  • •History of vestibular disorders, (such as vertigo)

研究组 & 干预措施

Group 1- "VirtuSom" - Stim

Active Comparator

Normal sleepers (7.5 - 9.0 hours), MSLT (multiple sleep latency test) >=14 min; phase-advance 5-hours studied under full polysomnogram (PSG) with active device (electric stimulation of the Vestibular nerve).

干预措施: Electric stimulation of the Vestibular Nerve - "VirtuSom" (Device)

Group 2- "VirtuSom"- Sham

Placebo Comparator

Normal sleepers (7.5 - 9.0 hours), MSLT >=14 min; phase-advance 5-hours studied under full polysomnogram (PSG) with placebo / sham device (NO electric stimulation of the Vestibular nerve).

干预措施: Electric stim of the Vestibular Nerve - "VirtuSom" - SHAM (Device)

结局指标

主要结局

Latency to Persistent Sleep (LPS)

时间窗: Treatment Night

Latency to Persistent Sleep is how long does it take for a person to fall asleep and stay asleep. This is measured in minutes. This is different from sleep onset latency as participants fall asleep, but may wake back up.

次要结局

  • Total Sleep Time (TST) in the First 2 Hours After Lights Out(Treatment night)
  • Scored Sleep Onset Latency (SOL on PSG)(Treatment Night)
  • Total Sleep Time (TST) in the First Hour After Lights Out(Treatment night)
  • Subjective Sleep Onset Latency (SOL)(Treatment night)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

Evaluation of Vestibular Stimulation to Help... | 临床试验